Action against Defendant, the former CEO of a breast implant company, for alleged concealment of information about the company’s only implant manufacturer ahead of a stock offering.  According to the SEC, Defendant CEO knew prior to the offering that a certification required for its manufacturer to sell products in the European Union had been suspended but failed to disclose the information to the general counsel and underwriters.  The SEC further alleges that Defendant CEO made false statements to those who asked about the manufacturer and attempted to destroy related records.

SEC Litigation Release